FDA Staff Gripped by RFK Jr.'s Controversial Remarks

This chapter recounts a tense meeting where FDA staff listened to RFK Jr. discuss sensitive issues like the deep state and the autism epidemic, provoking mixed reactions among attendees. It further explores the consequences of significant layoffs at HHS and how new tariff policies could jeopardize the drug approval process and the broader pharmaceutical supply chain.